Engflag

Cipro-Hexal

Quick links to important sections

Cipro-Hexal

There is no image.

Method of action: Antibacterial Broad Spectrum (Bactericidal), Bactericidal

Treatment option: Blepharitis, Blepharoconjunctivitis, Bronchiectasis, Gonorrhea, Infection, Infection,Bacterial, Infection,Urinary Tract, Middle Ear Infection, Keratitis, Keratoconjunctivitis

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cipro-Hexal

Property Description
Active ingredient Ciprofloxacin
Forms Film-coated tablets, solution for infusion, eye drops, ear drops
Pharmacological class Fluoroquinolone Antibiotic, Anti-infective agent
General purpose Elimination of susceptible bacterial pathogens
Origin Synthetic

What Type of Medicine is Cipro-Hexal (Ciprofloxacin)?

Cipro-Hexal is a pharmaceutical preparation containing the active substance, Ciprofloxacin, which is classified as a synthetic anti-infective agent. Ciprofloxacin is specifically known as a fluoroquinolone antibiotic. This means the compound is entirely man-made, or synthetic, rather than being derived from a natural source. Cipro-Hexal, produced by the manufacturer Hexal AG, represents a recognized branded formulation of this essential medicine. Its use is clinically supported by pharmacological studies that confirm its position as a broad-spectrum agent against various bacterial types.

Composition and Available Forms of Cipro-Hexal

The primary component of Cipro-Hexal is the active ingredient, Ciprofloxacin, typically supplied as a salt, such as the hydrochloride or monohydrate salt. This medicine is recognized for its versatility in delivery, being formulated for both systemic and local administration. The systemic forms include standard film-coated tablets for oral intake and a sterile solution for infusion for intravenous delivery. For focused, localized treatment, Cipro-Hexal is also manufactured as specific eye drops and ear drops. This range of dosage forms ensures the active agent is available for use in various infection sites.

What is the General Purpose of This Antibiotic?

The general purpose of this antibiotic is the elimination of susceptible bacterial pathogens that cause infections in the body. Ciprofloxacin achieves this by its bactericidal effect, meaning that, unlike some antibiotics that slow growth, it directly kills the targeted bacteria. This medicine is designed to effectively fight bacteria through its distinctive killing action. This action is essential for achieving a successful outcome against bacterial diseases, functioning by interfering with the bacteria's critical life processes, which is a hallmark of the fluoroquinolone class.

Regulatory References

  1. Ciprofloxacin - StatPearls - NCBI Bookshelf

What side effects are possible with Cipro-Hexal?

Cipro-Hexal (Ciprofloxacin) Safety Profile is defined by regulatory documents, which categorize potential adverse reactions based on their official frequency and the body systems affected.

Frequency-Classified Adverse Reactions

The adverse reactions are categorized according to the expected frequency observed in clinical use, following standard regulatory definitions:

  • Common (may affect up to 1 in 10 people): Nausea and Diarrhea.
  • Uncommon (may affect up to 1 in 100 people): Vomiting, Abdominal pain, Headache, Dizziness, Insomnia, Rash, and elevations in liver enzymes.
  • Rare (may affect up to 1 in 1,000 people): Peripheral neuropathy, Tendinitis, Photosensitivity, and Pseudomembranous colitis.
  • Very Rare (may affect up to 1 in 10,000 people): Tendon rupture and serious hypersensitivity reactions such as anaphylaxis.

Systemic and Serious Safety Considerations

The regulatory label identifies several System-Organ Classes involved, including Gastrointestinal disorders, Nervous system disorders, Musculoskeletal disorders, and Cardiac disorders. Within these categories, certain Serious Adverse Reactions are explicitly highlighted in the official labeling. These include Tendon Rupture and Peripheral Neuropathy, both of which may be potentially debilitating or irreversible. Other serious effects include central nervous system disturbances (e.g., seizures, psychosis) and prolongation of the QT interval on the heart.

Official safety statements note that time-related patterns exist for some risks; tendon rupture and neuropathy may occur within 48 hours of starting treatment or months after stopping the medicine. Population-specific safety is noted for Older Adults, who have an officially documented increased risk for severe tendon disorders.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose information for Cipro-Hexal (Ciprofloxacin) is documented in official government regulatory sources, which define the required emergency response. The officially described manifestations primarily involve the central nervous system (CNS), including dizziness, tremor, headaches, confusion, seizures, and hallucinations. Gastrointestinal effects such as abdominal discomfort are also recognized.

The regulatory profile highlights severe outcomes linked to organ toxicity, such as acute renal failure and hepatic impairment. Signs of renal stress documented in the label include crystalluria and haematuria. Specific high-dose cases, such as a reported overdose of 16g, were associated with acute renal failure.

Required Emergency Actions

Immediate medical attention is necessary upon the manifestation of any overdose symptoms for the implementation of required symptomatic treatment. Officially described procedures include routine emergency measures like ventricular emptying (gastric lavage) followed by the administration of medical carbon (activated charcoal). Patients must be kept well hydrated. Further management involves close monitoring of renal function and urinary pH to prevent crystallization in the urine. The label notes that no specific antidote is available and that elimination via haemodialysis or peritoneal dialysis is limited, removing less than 10% of the compound.

Therapeutic Uses of Cipro-Hexal

What Cipro-Hexal Treats: Main Uses and Benefits

Cipro-Hexal (Ciprofloxacin) is an anti-infective agent used for managing conditions caused by susceptible bacteria across several major body systems. Its core therapeutic benefit may support the process of addressing the underlying infection to help ease associated systemic and localized distress. Ciprofloxacin is used across a variety of bacterial diseases.

Addressing Symptom Clusters and Clinical Scenarios

The medication is commonly used to provide support in treating conditions that present with acute or disruptive symptom patterns, such as complicated urinary tract infections (including pyelonephritis), severe infectious diarrhea and typhoid fever, certain types of pneumonia, and deep-seated infections of the bone and joints. The medicine is relevant in contexts involving symptoms linked to organ-specific functional stress in the external ear canal and the eye.

This therapeutic use is relevant for managing symptoms that interfere with daily comfort. The medication is commonly used to provide support that helps ease the overall symptom burden, including high fever, pain, and localized discharge, and may assist with maintaining functional stability during periods of heightened symptoms.

Quick Fact: Symptom Management Contexts
Cipro-Hexal is applied when symptoms related to systemic imbalance (like high fever) and physical discomfort (like painful urination or flank pain) become more noticeable, contributing to easing the overall symptom load during periods of heightened symptoms.

Eligibility and Restrictions for Use

Cipro-Hexal (Ciprofloxacin) eligibility is strictly defined by regulatory documents, outlining populations for whom use is contraindicated, restricted, or conditional.

Classification Population Rule
Contraindicated Patients with a known hypersensitivity to ciprofloxacin or any other quinolone antibacterial. Also prohibited for patients receiving tizanidine and those with a history of myasthenia gravis (due to risk of exacerbating muscle weakness).
Restricted Use Use is not recommended in pregnant or breastfeeding women as defined in official labeling. Use in pediatric patients (under 18) is generally restricted to specific, severe infections (like complicated urinary tract infections or anthrax) due to potential musculoskeletal risks.

Age and Condition-Based Eligibility

Adults (18 years and older) are the approved standard population. Older adults require special caution due to increased risk of tendon damage and age-related decreased renal function. Patients with impaired renal function (e.g., severe creatinine clearance reduction) are conditional-use populations and typically require dosage modification as an explicit eligibility rule. Patients who have experienced a serious adverse reaction associated with fluoroquinolones (e.g., tendon rupture) are prohibited from subsequent use. Use requires caution in patients with conditions that predispose to QT interval prolongation or a history of tendon disorders.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cipro-Hexal (ciprofloxacin) may interact with several medicinal products and substance categories, affecting either the concentration of Cipro-Hexal or the other medicine.

Key Interactions and Management

Interacting Product Category Potential Effect & Clinical Relevance
Tizanidine Contraindicated. Coadministration is forbidden due to a major increase in Tizanidine levels, posing a high risk for severe side effects like hypotension and sedation.
Multivalent Cations (e.g., Magnesium/Aluminum Antacids, Iron, Zinc supplements, Sucralfate) Significantly decreased Cipro-Hexal absorption. These products must be administered at least 2 hours before or 6 hours after Cipro-Hexal to prevent therapeutic failure. Dairy products and calcium-fortified juices should not be taken alone with Cipro-Hexal.
CYP1A2 Substrates (e.g., Theophylline, Caffeine) Cipro-Hexal inhibits the metabolism of these drugs, leading to increased plasma concentrations and potential toxicity (e.g., seizures with Theophylline). Monitoring drug levels is required.
Warfarin Enhanced anticoagulant effect. Close monitoring of INR and prothrombin time is required during concurrent use to manage bleeding risk.
Anti-diabetic agents (Oral agents, Insulin) Risk of blood glucose disturbances (hypoglycemia or hyperglycemia), including serious and fatal outcomes. Blood glucose monitoring is necessary.
Probenecid Increased Cipro-Hexal concentrations due to reduction in Cipro-Hexal's renal clearance.
QT-Prolonging Drugs (e.g., Class IA and III Antiarrhythmics) Increased risk of QT interval prolongation and torsade de pointes.

Mechanism of Action

Targeting Bacterial DNA Management Enzymes

The mechanism of Ciprofloxacin focuses on the inhibition of two critical bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. These enzymes are vital for managing the complex, coiled structure of the bacterial chromosome during DNA replication. The molecule binds directly to the enzyme-DNA complex. By stabilizing this complex, the drug prevents the enzymes from re-ligating (rejoining) the cleaved DNA strands. This action represents the critical molecular step in the drug’s mechanism, establishing the bacterial DNA management system as the primary mechanistic domain.

The Cascade of Genetic Damage

The enzyme poisoning translates the trapped, cleaved DNA into permanent Double-Strand DNA Breaks (DSBs). The genetic damage halts cellular functions, including replication and protein synthesis, resulting in the physiological consequence of bacterial cell death. This cascade acts by directly destroying the structural integrity of the cell’s genome.

️ Constraints on the Mechanism’s Efficacy

The mechanism is subject to specific biological constraints within the pathogen. Point mutations in the target enzyme sites (QRDR region) can weaken the binding affinity of Ciprofloxacin, limiting its ability to poison the enzyme-DNA complex. Furthermore, the presence of efflux pumps can actively reduce the drug concentration inside the cell, thus constraining the overall mechanistic consequence.

Dosage and Administration Information

How to Use Cipro-Hexal

Cipro-Hexal (Ciprofloxacin) is administered according to specific, label-based instructions that govern the route, frequency, duration, and conditions of use. The medicine is primarily used via oral forms, such as film-coated tablets, or through intravenous (IV) infusion for systemic delivery. Specialized topical solutions are also available for localized use in the eye or ear.

Administration Protocol

Instruction Principle of Use
Dosing Schedule Systemic dosing for adults typically follows a twice-daily (q12h) regimen, with doses ranging from 250 mg to 750 mg orally or 200 mg to 400 mg via IV infusion.
Intake Timing Oral tablets may be taken with or without food; however, administration must be separated from products containing divalent or trivalent cations (e.g., antacids, iron supplements) by several hours.
Preparation Intravenous solutions require a slow infusion over 60 minutes to manage local administration effects. Oral tablets must be swallowed whole, and the liquid suspension must be shaken vigorously before measurement.

Course Duration and Adjustments

The treatment duration is highly variable, ranging from a single dose for specific, uncomplicated infections to multiple weeks (e.g., 4 to 8 weeks) for deep-seated or complex infections such as those involving bone and joint tissue. A crucial aspect of the usage protocol is dose adjustment for individuals with impaired kidney function, which requires reducing the dose amount or prolonging the interval between administrations based on creatinine clearance. The standard regimen requires that the full course of therapy be followed as prescribed, and a missed dose should be taken as soon as remembered unless it is close to the next scheduled dose time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cipro-Hexal

Evidence for Common and Deep-Seated Infections

Research explored the use of Cipro-Hexal (ciprofloxacin) in study participants with common infections, utilizing Randomized Controlled Trials (RCTs) and comparative clinical trials for conditions like complicated urinary tract infections (cUTI) and infectious diarrhea. These studies primarily examined outcomes such as clinical changes (monitored shifts in symptoms) and microbiological clearance (absence of the causative bacteria, measured at a defined threshold).

For deep-seated infections like bone and joint infections, research also monitored the drug concentration achieved within bone and muscle tissue, alongside observations of clinical changes during prolonged treatment courses. For localized conditions, such as eye and ear infections, studies explored short-term symptom shifts at the application site.

Scope of Evidence and Known Limitations

The research also covers specialized scenarios, including Typhoid Fever and Inhalational Anthrax. For anthrax post-exposure, evidence relies on human Pharmacokinetic (PK) studies combined with animal data, as efficacy trials in humans are not feasible.

Research has explored the agent in pediatric patients and older adults, though sample sizes were modest in many subgroup analyses. A key limitation is that long-term effects are not fully established across all indications. Furthermore, data from older studies may provide limited insight into current treatment response rates due to the global rise of bacterial resistance.

Key Studies & References

  1. Ciprofloxacin for Post-Exposure Prophylaxis of Anthrax - Emergency Use Instructions for Healthcare Providers (FDA/CDC)
  2. public assessment report (PAR) for Ciprinol 250, 500, and 750 mg film-coated tablets - European Regulatory Document (MEB/EMA)
  3. Evaluation of the Efficacy and Tolerability of Oral Ciprofloxacin used in the Comprehensive Treatment of External Bacterial Otitis: An Observational Prospective Study (International Archives of Otorhinolaryngology, 2018)

Frequently Asked Questions (FAQ)

Common questions about Cipro-Hexal (FAQ)

Q: How quickly does Cipro-Hexal start to work?

A: According to official regulatory information, the medicine is rapidly and well absorbed after taking an oral dose. Maximum concentration of the active substance in the blood is reached within approximately one to two hours after administration. However, the time it takes to see clear clinical improvement in your infection may be longer, often requiring two to three days.

Q: How long does Cipro-Hexal stay in your system after the last dose?

A: Studies on the elimination of Cipro-Hexal show that in people with normal kidney function, the body processes and removes the drug. The elimination half-life of the medicine is approximately four hours. This refers to the time it takes for the drug concentration in the body to decrease by half. Most of the drug is generally excreted within 24 hours of the last dose.

Q: Is it okay to drink coffee while taking Cipro-Hexal?

A: Official drug information indicates that Cipro-Hexal can inhibit the metabolism of caffeine, which slows down how your body breaks down caffeine. This may result in an increased concentration of caffeine in the body, potentially leading to a higher risk of caffeine-related side effects.

Q: Do you need to avoid dairy products when taking Cipro-Hexal?

A: Official administration instructions recommend against taking Cipro-Hexal tablets at the exact same time as dairy products (like milk or yogurt) or calcium-fortified juices. These contain multivalent cations (charged minerals) that can significantly reduce the medicine's absorption. However, these items may generally be consumed when taken as part of a meal.

Q: Can Cipro-Hexal affect your sleep?

A: Yes, regulatory documents list effects on the nervous system. Insomnia, or difficulty sleeping, is listed as an uncommon side effect of the medicine. Other central nervous system effects are also reported in official product information.

Q: Are there any vitamins or supplements that interact with Cipro-Hexal?

A: Yes, supplements containing multivalent cations can interact significantly. This includes minerals like Iron, Zinc, Magnesium, and Calcium. The administration of these products should be separated by several hours from the antibiotic dose, as taking them simultaneously may significantly decrease the absorption of Cipro-Hexal.

Q: Why do doctors tell you to avoid sun exposure while on Cipro-Hexal?

A: The reason for this is that Photosensitivity (increased sensitivity to the sun or ultraviolet light) is listed as a rare adverse reaction to Cipro-Hexal. Official labeling advises caution regarding unnecessary sun exposure or the use of protective measures during treatment.

Q: Can Cipro-Hexal affect your mood or cause anxiety?

A: Cipro-Hexal has been officially associated with psychiatric reactions. Anxiety is listed as a potential effect on the central nervous system, and it is noted that this can occur after the first dose. Serious mood or behavior changes are also reported as a possible risk associated with the drug.

Q: Does Cipro-Hexal have an impact on birth control effectiveness?

A: Information suggests that some antibiotics in this class, including ciprofloxacin, may potentially reduce the effectiveness of oral contraceptives that contain ethinyl estradiol. Because of this potential interaction, regulatory documents suggest the need for monitoring during concurrent use.

Q: Is Cipro-Hexal the same kind of drug as Azithromycin?

A: No, these are different classes of antibiotics. Cipro-Hexal (ciprofloxacin) is a fluoroquinolone antibiotic, which works by interfering with the bacteria’s DNA enzymes. Azithromycin, by contrast, is a macrolide antibiotic, which works by stopping bacteria from making necessary proteins.

Q: Are the side effects of Cipro-Hexal permanent?

A: Official warnings note that certain serious adverse reactions associated with this class of antibiotics, specifically Tendon Rupture and Peripheral Neuropathy (nerve damage), may be disabling and potentially irreversible in some patients. This warning applies specifically to these rare, serious adverse events.

Q: Does Cipro-Hexal interact with any common heart medications?

A: Yes, Cipro-Hexal is known to interact with certain heart medicines. It is associated with a risk of QT interval prolongation (a change in the heart's electrical activity) and should be used with caution, or avoided, with other medicines that also prolong the QT interval. The concurrent use with Warfarin also requires close observation due to the potential for an enhanced anticoagulant effect.

Q: Is it okay to take Cipro-Hexal with a meal or on an empty stomach?

A: According to official dosage and administration instructions, oral tablets may be taken with or without food. Taking the medicine with meals may result in a slight delay in its absorption, but this does not typically affect its overall effectiveness.

Q: How is Cipro-Hexal different from antibiotics like amoxicillin?

A: Cipro-Hexal (ciprofloxacin) and amoxicillin belong to different drug classes. Cipro-Hexal is a fluoroquinolone, while amoxicillin is a penicillin-class antibiotic. They target bacteria using completely different mechanisms, making them suitable for use against different bacterial types and infections.

Q: Do you feel tired or fatigued when taking Cipro-Hexal?

A: While tiredness is not listed as a common side effect in official reports, fatigue has been noted as a potential symptom in connection with some of the drug's more serious adverse effects, such as nervous system disorders or liver injury. The complete list of known adverse reactions is detailed in official product information.

Q: Can Cipro-Hexal affect your blood sugar levels?

A: Yes. Cipro-Hexal has been associated with blood glucose disturbances, including both hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar). This risk is particularly noted in official drug information for patients who are also taking anti-diabetic agents.

Q: What happens if you miss a dose of Cipro-Hexal?

A: Regulatory instructions state that a missed dose should be taken as soon as it is remembered, unless it is nearly time for the next scheduled dose. If it is close to the next scheduled dose time, the missed dose is typically skipped, and the regular schedule is resumed. Double dosing is not recommended.

Q: Is it normal to feel dizzy or lightheaded after taking Cipro-Hexal?

A: Dizziness is listed as an uncommon side effect in official product information. Central nervous system stimulation, which can cause a transient feeling of light-headedness, is also a reported effect. If persistent or severe dizziness occurs, consultation with a healthcare professional is recommended.

Q: Why is Cipro-Hexal often prescribed for UTIs?

A: Cipro-Hexal is highly effective against many of the common bacteria that cause urinary tract infections (UTIs), particularly E. coli. Pharmacological studies demonstrate that the drug achieves high concentrations in both the kidneys and the urine, allowing it to effectively target and eliminate the bacteria at the site of infection.

Q: Is Cipro-Hexal used for traveler's diarrhea?

A: Yes, ciprofloxacin is indicated for the treatment of certain cases of infectious diarrhea. Restrictions in some regulatory regions advise against its use for the prevention of traveler’s diarrhea or for treating non-severe infections when alternative options are suitable.

Q: Can Cipro-Hexal be used to treat skin infections?

A: Yes, Cipro-Hexal is officially indicated for the treatment of certain skin and skin structure infections. The specific type of skin infection must be caused by a bacterial pathogen that is known to be susceptible to ciprofloxacin.

Q: Can Cipro-Hexal make you more sensitive to light?

A: Yes, official safety documents list Photosensitivity (increased sensitivity to sunlight or UV light) as a rare side effect. Official warnings advise caution regarding unnecessary exposure to the sun or suggest the use of protective measures during treatment.

Q: Is Cipro-Hexal effective against C. difficile?

A: No. Fluoroquinolone antibiotics, including Cipro-Hexal, have been associated with an increased risk of developing Clostridioides difficile-associated diarrhea (CDAD). This condition is a potentially severe infection of the colon and its treatment involves specific non-fluoroquinolone antibiotics.

Q: Does Cipro-Hexal interact with alcohol?

A: Regulatory documents state that there is no known direct interaction between Cipro-Hexal and alcohol. However, it is noted that alcohol consumption could potentially intensify some of the medicine's common side effects, such as dizziness or digestive issues.

Q: Can Cipro-Hexal cause a headache?

A: Yes, official safety information lists headache as an uncommon side effect. Furthermore, severe headache is a reported symptom associated with some of the more serious nervous system adverse reactions.

Q: Is it necessary to take probiotics with Cipro-Hexal?

A: Regulatory-aligned information indicates that the effects of Cipro-Hexal may be lessened if it is taken simultaneously with certain probiotic formulas. If probiotic formulas are used, official guidance recommends they be administered at least one to two hours before or after Cipro-Hexal to help prevent a reduction in the drug's effectiveness.

Q: Does Cipro-Hexal have a metallic taste?

A: While a specific 'metallic taste' is not consistently detailed in official documents, a general alteration or disturbance of taste, known as dysgeusia, is listed as a potential side effect. This indicates that some patients may experience a change in how things taste.

Q: Why is Cipro-Hexal sometimes prescribed for bone infections?

A: Cipro-Hexal is indicated for the treatment of bone and joint infections. This is supported by pharmacological studies showing that the drug is widely distributed throughout the body and is able to penetrate and achieve detectable concentrations within bone and cartilage tissue, making it suitable for deep-seated infections.

Q: Is there a risk of developing antibiotic resistance with Cipro-Hexal?

A: The drug's labeling emphasizes that it should be reserved for treating or preventing infections proven or strongly suspected to be caused by susceptible bacteria, as unnecessary use contributes to the risk of developing drug-resistant bacteria.

How should Cipro-Hexal be stored and disposed of?

How to Store and Dispose of Cipro-Hexal (Ciprofloxacin)

The medicine must be stored according to regulatory requirements to maintain stability and safety. Cipro-Hexal tablets should not be stored above 30 °C (86 °F) and must be kept in the original, tightly closed container protected from light.

Storage of Oral Suspension

The prepared oral suspension should be stored below 30 °C but must not be frozen. The mixed liquid is stable for 14 days and must be discarded afterward. All forms must be kept out of the sight and reach of children.

Official Disposal

Expired or unused product must not be thrown away into wastewater or household trash. Disposal should follow environmental safety protocols, such as returning the medicine to a pharmacy take-back program or adhering to local authority guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagSouth Africa

Equivalent of Cipro-Hexal found in:

A-Z Index: